← Browse by Condition
Medical Condition

renal insufficiency chronic

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for renal insufficiency chronic sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — renal insufficiency chronic Clinical Trials

How many clinical trials are currently recruiting for renal insufficiency chronic?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for renal insufficiency chronic, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for renal insufficiency chronic?
renal insufficiency chronic research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a renal insufficiency chronic clinical trial?
Eligibility criteria for renal insufficiency chronic trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 4
1
Top Sponsors
Christian Medical College, Vellore, India 1 trial
Alexandria University 1 trial
Emory University 1 trial
Zhen Li 1 trial

Recruiting Clinical Trials

NCT06676384 Phase 4
Recruiting

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

Enrollment
585 pts
Location
India
Sponsor
Christian Medical College, Vel...
View Trial →
NCT07522944
Recruiting

AI-Guided Relaxation for Hemodialysis Anxiety

Enrollment
60 pts
Location
Egypt
Sponsor
Alexandria University
View Trial →
NCT02947750 Phase 2
Recruiting

Neurovascular Transduction During Exercise in Chronic Kidney Disease

Enrollment
150 pts
Location
United States
Sponsor
Emory University
View Trial →
NCT06366529
Recruiting

Explore New Magnetic Resonance Technology in Assessment of Renal Dysfunction

Enrollment
500 pts
Location
China
Sponsor
Zhen Li
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology